Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain tumor patients test safer radiation: proton vs. photon

NCT ID NCT05190172

First seen May 01, 2026 · Last updated May 01, 2026

Summary

This study compares two types of radiation therapy for people with IDH-mutated grade 2 or 3 gliomas, a type of slow-growing brain tumor. The goal is to see if proton therapy, which targets tumors more precisely, is as effective as standard photon therapy at controlling the tumor while causing fewer side effects. About 225 adults aged 18 to 65 will be randomly assigned to receive either proton or photon radiation, and researchers will track survival, quality of life, and fatigue over two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIFFUSE ASTROCYTOMA, IDH-MUTANT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Oslo University Hospital

    RECRUITING

    Oslo, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.